You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Merck
Express Scripts
Baxter
Mallinckrodt

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for CAM2038


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for CAM2038?

CAM2038 is an investigational drug.

There have been 9 clinical trials for CAM2038. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2020.

The most common disease conditions in clinical trials are Disease, Substance Withdrawal Syndrome, and Opioid-Related Disorders. The leading clinical trial sponsors are Braeburn Pharmaceuticals, Theresa Winhusen, PhD, and The EMMES Corporation.

There are two US patents protecting this investigational drug and twenty-six international patents.

Recent Clinical Trials for CAM2038
TitleSponsorPhase
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyNational Institute on Drug Abuse (NIDA)Phase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyThe EMMES CorporationPhase 3
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyTheresa Winhusen, PhDPhase 3

See all CAM2038 clinical trials

Clinical Trial Summary for CAM2038

Top disease conditions for CAM2038
Top clinical trial sponsors for CAM2038

See all CAM2038 clinical trials

US Patents for CAM2038

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CAM2038   Start Trial Tactile sensing device for lumbar punctures TEXAS MEDICAL CENTER (Houston, TX)   Start Trial
CAM2038   Start Trial Methods and devices to reduce damaging effects of concussive or blast forces on a subject TBI INNOVATIONS, LLC (Richmond, IN) THORNHILL RESEARCH, INC. (Toronto, Ontario, CA)   Start Trial
CAM2038   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
CAM2038   Start Trial Therapeutic compounds and methods of use thereof GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA)   Start Trial
CAM2038   Start Trial Heterocyclic flavone derivatives, compositions, and methods related thereto Emory University (Atlanta, GA)   Start Trial
CAM2038   Start Trial Transdermal dosage form Barr Laboratories, Inc. (Pomona, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for CAM2038

Drugname Country Document Number Estimated Expiration Related US Patent
CAM2038 Australia 2017260251 2036-05-03   Start Trial
CAM2038 Canada 3022932 2036-05-03   Start Trial
CAM2038 China 109414220 2036-05-03   Start Trial
CAM2038 European Patent Office 3451925 2036-05-03   Start Trial
CAM2038 Israel 262739 2036-05-03   Start Trial
CAM2038 Japan 2019522503 2036-05-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Moodys
AstraZeneca
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.